Confluent Medical Sees Dramatic Improvements Around Supply Chain Visibility and Efficiency
Confluent Medical, a leading materials science, development and manufacturing partner to medical device manufacturers (“OEMs”), has experienced significant improvements to its end-to-end supply chain with Kinaxis. The medical technology (medtech) innovator, that delivers life-saving implants, minimally invasive delivery systems and other medical devices, deployed Kinaxis® in August 2023 with the help of Genpact and credits increased visibility and efficiency to the partnership.
The company specializes in the design, development and large-scale manufacturing of catheter-based devices and Nitinol components – a specialized metal alloy with super-elasticity and shape memory. With 8 facilities across the United States and Costa Rica, 2,000 employees and a wide range of products including complex catheters, high-precision polymer tubing and implantable textiles, the ability to react to any changes in any part of their supply chain quickly was paramount.
Jeff McCoun, vice president, global supply chain at Confluent Medical said, “We had a demand peak that nearly doubled and normally it would have taken months to re-sync our supply chain, but we did it in just weeks. Before Kinaxis, we were running separate spreadsheets for every part of the chain, no one was ever on the same page and if a change happened somewhere, it was never clear to anyone else in the chain. I’ve used other solutions over the course of my career, but I’ve never witnessed as fast and efficient a deployment and improvement as what we’ve seen with Kinaxis.”
Claire Rychlewski, executive vice president, global field sales at Kinaxis said, “Making this type of impact is what drives us. Confluent’s vision is to improve lives by delivering world-class medical devices through innovative material science, engineering, and manufacturing, and we are thrilled to be helping them do that. That’s a big win for all of us.”
Genpact began the Confluent Medical solution design in late 2022 and roll out to more sites and more users is already underway.
Kinaxis works with some of the biggest brands in the world across all sectors including CPG, automotive, high tech, life sciences and more. Its AI-powered technology and patented concurrency technique allows companies to orchestrate their supply chain network end-to-end from strategic planning to last-mile delivery.
Kinaxis is the global leader in modern supply chain management. We serve supply chains and the people who manage them in service of humanity. Our software is trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. We combine our patented concurrency technique with a human-centered approach to AI to empower businesses of all sizes to orchestrate their end-to-end supply chain network, from multi-year strategic planning through down-to-the-second execution and last-mile delivery. For more news and information, please visit Kinaxis.com or follow us on LinkedIn.
About Confluent Medical
Confluent Applies Materials Science to MedTech Innovation. Confluent specializes in the expert design, development, and large-scale manufacturing of interventional catheter-based devices and implants. Customers rely on Confluent’s expertise in Nitinol material and components, balloon and complex catheters, high-precision polymer tubing, and implantable textiles. With facilities in Fremont and Orange County, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; and San Jose, Costa Rica, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering, and manufacturing. For more information, visit confluentmedical.com.
Genpact (NYSE: G) is a global professional services firm delivering the outcomes that transform our clients' businesses and shape their future. We're guided by our real-world experience redesigning and running thousands of processes for hundreds of global companies. Our clients – including many in the Global Fortune 500 – partner with us for our unique ability to combine deep industry and functional expertise, leading talent, and proven methodologies to drive collaborative innovation that turns insights into action and delivers outcomes at scale. We create lasting competitive advantages for our clients and their customers, running digitally enabled operations and applying our Data-Tech-AI services to design, build, and transform their businesses. And we do it all with purpose. From New York to New Delhi and more than 30 countries in between, our 115,000+ team is passionate in its relentless pursuit of a world that works better for people. Get to know us at Genpact.com and on LinkedIn, Twitter, YouTube, and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Jaime Cook | Kinaxis
Rick Wadsworth | Kinaxis
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AudioCure Pharma Receives Hearing Technology Innovator Award for its Innovative Compound AC102 for the Treatment of Sudden Hearing Loss7.12.2023 10:05:00 CET | Press release
AudioCure Pharma GmbH announced today that it has been awarded for its innovative compound AC102 by the Hearing Technology Innovator Awards™, honoring technological innovation and breakthroughs in the hearing industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231205308215/en/ Dr. Reimar Schlingensiepen (left, CEO of AudioCure Pharma GmbH) and Prof. Hans Rommelspacher (founder and CSO) receive the award in the therapeutics category. (Photo: AudioCure Pharma) AudioCure is developing the therapeutic small molecule AC102 to treat hearing impairments including Sudden Sensorineural Hearing Loss (SSNHL). While corticosteroids are the standard treatment, health authorities have never approved them as there is no clear evidence of a clinically relevant benefit to the patient. AudioCure is conducting extensive research to develop targeted and effective therapies to address this high unmet medical need. In preclinical hearing los
FourKites Unveils Supply Chain Training Platform to Help Customers Maximise Value and Increase ROI7.12.2023 10:03:00 CET | Press release
Leading supply chain visibility provider FourKites today announces the availability of FourKites Academy, a comprehensive training platform designed to help supply chain professionals advance in their careers and business goals with high-quality, industry-recognised training resources. In addition to offering a Council of Supply Chain Management Professionals (CSCMP)-accredited course, the Academy helps FourKites customers and their extended ecosystem — including third-party logistics providers (3PLs), carriers, brokers and transportation management partners — keep pace with FourKites’ latest innovations and derive maximum value from the platform. According to research from the 2023 MHI Annual Industry Report, hiring and retaining qualified workers is the top challenge for supply chain leaders, with 41% indicating that reskilling and training their workforce is key to preparing for future disruptions. “Through FourKites Academy, we are empowering supply chain professionals with new ski
The 5th World Media Summit (Yunnan Branch) and the 2nd Yunnan International Communication Forum Kicks off in Kunming, China7.12.2023 09:43:00 CET | Press release
The 5th World Media Summit (Yunnan Branch) and the 2nd Yunnan International Communication Forum kicked off on December 6, 2023, in Kunming, the capital city of Yunnan Province in Southwestern China, gathering more than 300 representatives of around 80 institutions, including media outlets, international organizations and think tanks, from nearly 30 countries and regions . This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231206795498/en/ The 5th World Media Summit (Yunnan Branch) and the 2nd Yunnan International Communication Forum kicks off in Kunming on Dec. 5 (Photo: Business Wire) The opening of the summit on December 5 witnessed the adoption of the Kunming Initiative, the launch of a theme activity named "A Lifestyle Called Yunnan", as well as the release of the list of trending words for international communication generated by Xinhuanet. According to the agenda of the summit, the attendees will discuss a variety of topic
euNetworks’ CEO delivers insight at COP28 on the company’s sustainability focus7.12.2023 09:00:00 CET | Press release
euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, was recently featured in an interview series with leaders from across industries undertaken during the United Nations Climate Conference (COP28) in Dubai. The series of interviews captures lessons learned, sustainability success stories and key messages for the future from leaders across the energy, technology and telecom, manufacturing and finance industries. euNetworks has also released its latest Sustainability Report, detailing the company’s commitment to sustainability and substantial progress over the last year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231207410743/en/ Paula Cogan, CEO of euNetworks (Photo: Business Wire) euNetworks builds and invests in city and long haul fibre networks to connect key European data centres and data hubs. The company owns and operates deep fibre networks in 17 cities and also operates a
Ecopol Announces Strategic Investment in JRF Technology7.12.2023 09:00:00 CET | Press release
Ecopol S.p.A. (“Ecopol”), a leading developer and producer of innovative biodegradable films and delivery systems, announced today it has completed a strategic investment in JRF Technology LLC (“JRF” or the “Company”), a leading developer of water-soluble polymer and edible film technology. Founded in 2007 and based in Tampa, Florida, JRF is an innovation and R&D organization focused exclusively on water-soluble polymer and edible film technology. From its state-of-the-art GMP laboratory, JRF provides innovation services to clients ranging from leading multinational consumer goods companies to innovative start-ups. The Company has unique expertise in product development and process technology to convert water-soluble polymers into value-added commercial products. JRF will continue to be led by President James Rossman and Managing Director Richard Fielder and will serve as Ecopol’s U.S. R&D Center of Excellence, complementing its R&D capabilities in Italy. “Our strategic investment in J